[1] Centers for Disease Control and Prevention of USA. Coronavirus Disease2019 (COVID-19)[EB/OL]. https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/summary.html#emergence. [2] Sifuentes-Rodríguez E, Palacios-Reyes D.COVID-19: The outbreak caused by a new coronavirus[J]. Bol Med Hosp Infant Mex, 2020, 77(2):47-53. [3] Yang Y, Peng F, Wang R.The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China[J]. J Autoimmun, 2020, 3:102434. [4] Alfonso JR, Jaime A, Estefanía GO.Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis[J]. Travel Med Infect Dis, 2020, 34: 101623 [5] World Health Organization.WHO Director-General's opening remarks at the media briefing on COVID-19-10 August 2020[EB/OL]. [2020-8-10].https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---10-august-2020. [6] 国家卫生健康委办公厅. 新型冠状病毒肺炎诊疗方案(试行第七版)[J]. 传染病信息, 2020, 33(1):1-6+26. [7] 许莹,钱雅君,顾勤,等.新型冠状病毒肺炎患者D-二聚体与炎性因子和器官功能的关系探讨[J].中华危重病急救医学, 2020, 32(5): 559-563. [8] Muhammad AS, Suliman K, Abeer K.COVID-19 infection: origin, transmission, and characteristics of human coronaviruses[J]. J Adv Res, 2020, 24:91-98. [9] 徐哲, 赵磊, 王福生, 等. 病毒性肺炎[J]. 传染病信息, 2020, 33(1):41-44. [10] 陆国平,陈伟明. 重症病毒性肺炎与心功能不全[J]. 中国小儿急救医学, 2015, 22(12):826-828+835. [11] Guo W, Li M, Dong Y.Diabetes is a risk factor for the progression and prognosis of COVID-19[J]. Diabetes Metab Res Rev, 2020, 31:e3319. [12] Chih CL, Yen HL, Cheng YW.Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (2019-nCoV): Facts and myths[J]. J Microbiol Immunol, 2020, 53(3):404-412. [13] Han H, Xie L, Liu R.Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China[J]. J Med Virol, 2020, 92(7):819-823. [14] Sun ML, Yang JM, Sun YP.Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia[J]. Zhonghua Jie He He Hu Xi Za Zhi, 2020, 43(3):219-222. [15] 周婧,杨鸣,张铮,等. 新型冠状病毒导致多器官功能衰竭的机制探讨[J]. 中华老年多器官疾病杂志, 2020, 19(3): 226-228. [16] Mourad JJ, Levy BI.Interaction between RAAS inhibitors and ACE2 in the context of COVID-19[J]. Nat Rev Cardiol, 2020, 17(5):313. [17] Hao Xu,Liang Zhong,Jiaxin Deng,et al.High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa[J]. Int J Oral Sci, 2020, 12(01):77-81. [18] Tarasenko TN, Cusmano-Ozog K, McGuire PJ. Tissue acylcarnitine status in a mouse model of mitochondrial β-oxidation deficiency during metabolic decompensation due to influenza virus infection[J]. Mol Genet Metab, 2018, 125(1-2):144-152. [19] Erika P,Domenica Z,Paolo I,et al.Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients[J]. Clin Chim Acta, 2020 , 509: 135-138. [20] Feng Y, Xiong Y, Qiao T, et al.Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy[J]. Cancer Med, 2018,7(12):6124-6136. [21] Granchi C, Bertini S, Macchia M, et al.Inhibitors of lactate dehydrogenase isoforms and their therapeutic potentials[J]. Curr Med Chem, 2010, 17(7):672-697. [22] Mercer RM, Corcoran JP, Porcel JM, et al.Interpreting pleural fluid results[J]. Clin Med, 2019, 19(3):213-217. [23] Jurisic V, Radenkovic S, Konjevic G.The Actual Role of LDH as Tumor Marker, Biochemical and Clinical Aspects[J]. Adv Exp Med Biol, 2015, 867:115-124. [24] 李翠芝, 李美瑜, 甘露,等. 新型冠状病毒肺炎患者合并心脏和肝脏损害的临床分析[J/OL]. 广东医学:1-4[2020-04-01].https://doi.org/10.13820/j.cnki.gdyx.20200814. |